This blog post is taken from a recent Webinar featuring Jill Warrington, MD, PhD., Chief Medical Officer, Aspenti Health and Assistant Professor, Robert Larner College of Medicine, University of Vermont.
The Opioid crisis was already a significant problem for healthcare before the COVID-19 pandemic began to change everything. Dr. Jill Warrington began her discussion of how COVID-19 has reshaped the opioid crisis with a look back at what was happening before COVID-19 really emerged as a threat in 2019. “It is important to understand where we were then, if we are to really understand the impact that COVID-19 has had on the opioid crisis,” said Warrington.
Warrington and her colleagues use a number of metrics to help them evaluate the status of various opioid-related issues. There are three metrics on which Dr. Warrington and her colleagues are particularly focused. They are:
However, Warrington points out that this metric has some limitations. First, there are still many patients on waiting lists for treatment, so it is not necessarily a real indicator of system capacity. Secondly, Warrington points out that just 10% to 30% of SUD (Substance Use Disorder) patients are in care which means that 70% to 90% of those patients are not being served despite a much-expanded network of buprenorphine-waivered [BP1] providers.
There has been a steady decline in this metric since 2012 – the peak prescribing year. However, Warrington points out that providers are still prescribing enough opioids to support 50% of the population. While the momentum is in the right direction, the US has still not made the progress seen in some other countries.
Warrington describes the ecosystem that supports opioid use disorder patients as “already fragile,” as 2019 rolled over into 2020. There are more buprenorphine providers, but the number still falls short of what is needed. There have been reductions in the number of opioid prescriptions, but the reduction is probably not sufficient. And finally, while somewhat abated, the number of overdoses is still rising.
According to the American Medical Association, as of June 18, 2020, there were more than 30 states reporting increases in opioid-related deaths, mental health crises, suicide, and relapse. In addition, there are some rather alarming statistics on the use of drugs and alcohol during the pandemic. Warrington shared that:
While these figures may be somewhat shocking, they probably should not really surprise us. The pandemic has caused considerable economic and social distress with the loss of jobs creating financial stress for many and the loss of viable options for childcare creating considerable stress for those that still do have jobs. Concerns about health and the health of family members also creates additional stress.
In addition, while the healthcare delivery system including providers, payors, and in some cases, the government, has responded to the pandemic in a truly heroic fashion, it was also fundamentally unprepared to deal with the crisis. Treatment centers that were underfunded found themselves struggling and most reported having to make reductions in their services in order to remain open.
Lastly, and perhaps most significantly, there are factors specific to addiction that make the pandemic more dangerous for these patients. Factors such as social isolation, the exacerbation of existing mental health issues and the risk of COVID-19 complications. To learn more about these factors and Warrington’s recommendations for moving forward, click here to access the entire webinar.
HealthStream provides training solutions focused on improved patient outcomes. Using the right tools to help clinicians make informed decisions and reduce costly mistakes minimizes risk while maximizing competence. An outcomes-based delivery system requires it. HealthStream has partnered with Aspenti Health to offer a comprehensive and cost-effective way to drive the responsible administration of opioids and effectively identify and address opioid use disorder. Learn more at HealthStream.com/Aspenti
Fulfill compliance requirements with a variety of programs and courseware designed to address critical regulatory requirements as well as educate staff to recognize and mitigate risks.View All Products
Improve quality of care by reducing medical errors and harmful outcomes from improper technology or medication usage by giving clinical staff access to the engaging, interactive content they need to address patient safety issues.View All Products